Premium
Angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers benefits outweigh the risks in COVID‐19 hypertensive patients
Author(s) -
Ateya Areej Mohamed,
Sabri Nagwa A.
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26672
Subject(s) - pharmacy , medicine , angiotensin receptor blockers , clinical pharmacy , family medicine , angiotensin converting enzyme , blood pressure